Details

Autor(en) / Beteiligte

• Godone, R.L.N.
• Leitão, G.M.
• Araújo, N.B.
• Castelletti, C.H.M.
• Lima-Filho, J.L.
• Martins, D.B.G.

Titel

Clinical and molecular aspects of breast cancer: Targets and therapies

Ist Teil von

• Biomedicine & pharmacotherapy, 2018-10, Vol.106, p.14-34

Ort / Verlag

France: Elsevier Masson SAS

Erscheinungsjahr

2018

Quelle

Access via ScienceDirect (Elsevier)

Beschreibungen/Notizen

• Breast Cancer is a complex disease characterized by the occurrence of multiple molecular alterations. Currently, some molecular markers are in use for breast cancer diagnostic, prognostic, and predictive purposes. Thus, genetic signatures are available for improving the decision-making. The biomarkers are also essential as therapeutic approaches, but many questions remain due to the lack of efficacy on breast cancer treatment, mainly for triple-negative breast cancer subtype. Since the genetic profile of breast cancer can also be related to different ethnic groups and geographic areas, the reference populations of the genetic assays and clinical trials need to include a broader population beyond the European and North American patients. In this review, we analyzed the current and potential molecular markers that could help to improve the strategies for breast cancer therapy.